Table 1—

Background data for diabetic patients with normal (non-PAD group) or abnormal (PAD group) ABI and age-matched nondiabetic subjects (control group)

Control groupNon-PAD groupPAD group
ABI1.13 ± 0.091.15 ± 0.110.70 ± 0.13
n3317632
Sex (male/female)17/16103/73*27/5
Age (years)60.1 ± 6.560.9 ± 6.463.6 ± 6.0
BMI (kg/m2)22.6 ± 2.023.9 ± 3.422.7 ± 3.9
Duration of diabetes (years)14.2 ± 8.517.5 ± 10.2
Treatment (D/OHD/I)9/67/1002/12/18
FPG (mmol/l)5.30 ± 0.408.12 ± 2.268.17 ± 2.37
HbA1c (%)4.7 ± 0.48.8 ± 1.7*8.1 ± 1.4
TC (mmol/l)4.89 ± 0.625.00 ± 0.904.83 ± 0.80
HDL cholesterol (mmol/l)1.38 ± 0.421.22 ± 0.371.12 ± 0.30
TGs (mmol/l)1.14 ± 0.331.46 ± 0.781.38 ± 0.47
sBP (mmHg)122 ± 7132 ± 12*138 ± 14
dBP (mmHg)76 ± 871 ± 1072 ± 13
Smokers (%)14 (42)69 (39)§29 (91)
CVR-R (%)3.2 ± 1.02.1 ± 1.12.1 ± 0.9
Retinopathy (%)106 (60)21 (66)
Nephropathy (%)83 (47)18 (56)
  • Data are means ± SD or n (%). D, diet; OHD, oral hypoglycemic drugs; I, insulin.

  • P < 0.05,

  • P < 0.001 vs. the control group;

  • *

    * P < 0.05,

  • §

    § P < 0.01 vs. the PAD group.